During the past decade, St. Tammany Parish Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "St. Tammany Parish Hospital" are "Critical COVID-19 With Respiratory Failure" (1 trials), "Group B Streptococcus Infections" (1 trials) and "Respiratory Tract Infection" (1 trials). Many other conditions were trialed in "St. Tammany Parish Hospital" in a lesser frequency.

Most popular intervention types in "St. Tammany Parish Hospital" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Multivalent Group B streptococcus vaccine" (1 trials), "RSVpreF" (1 trials) and "ZYESAMI (aviptadil acetate)" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Tammany Parish Hospital" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "St. Tammany Parish Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in St. Tammany Parish Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Tammany Parish Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".